Publicaciones en colaboración con investigadoras/es de University of Oxford (5)

2010

  1. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  2. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

  3. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): A major ATP-binding residue

    Diabetic Medicine, Vol. 27, Núm. 2, pp. 225-229

2006

  1. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes

    Pflugers Archiv European Journal of Physiology, Vol. 453, Núm. 3, pp. 323-332